Genomic, serologic, and clinical case-control study of Chlamydia pneumoniae and peripheral artery occlusive disease

Journal of Vascular Surgery

Volumn 40, Issue 2, 2004, Pages 359-366

  Linares Palomino, Jose P ^a   Gutiérrez, Jose ^b   Lopez Espada, Christina ^c   Luna, Juan De Dios ^d   Ros, Eduardo ^a   Maroto, Carmen ^b  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Department of Microbiology ^*  (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; BLOOD VESSEL BIOPSY; CHLAMYDOPHILA PNEUMONIAE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; IMMUNOFLUORESCENCE TEST; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; SAPHENOUS VEIN; SEROLOGY; VARICOSIS; ARTERY; BACTERIAL INFECTION; CASE CONTROL STUDY; CHEMISTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

AGED; ARTERIAL OCCLUSIVE DISEASES; ARTERIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 3442884799     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2004.04.027     Document Type: Article

References (57)

1. Osler W. Diseases of the arteries. Osler W. Modern medicine: its practice and theory. 1908;429-447 Lea & Febiger, Philadelphia (PA)
2. Fabricant C.G. Atherosclerosis the consequence of infection with a herpes virus. Adv Vet Sci Comp Med. 30:1985;39-66
3. Smieja M., Gnarpe J., Lonn E., Gnarpe H., Olsson G., Yi Q., et al. Heart Outcomes Prevention Evaluation (HOPE) study investigators. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation. 107:2003;251-257
4. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., et al. Serologic evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 11:1988;983-986
5. Everett K., Bush R., Andersen A. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol. 49:1999;415-440
6. Thom D., Wang S., Grayston J., Siscovick D.S., Stewart D.K., Kronmal R.A., et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb. 11:1991;547-551
7. Saikku P., Leinonen M., Tenkanen L., Linnanmaki E., Ekman M.R., Manninen V., et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 116:1992;273-278
8. Leinonen M., Linnanmaki E., Mattila K., Nieminen M.S., Valtonen V., Leirisalo-Repo M., et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathogen. 9:1990;67-73
9. Shor A., Kuo C.C., Patton D.L. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 82:1992;158-161
10. Wong Y.K., Gallagher P.J., Ward M.E. Chlamydia pneumoniae and atherosclerosis. Heart. 81:1999;232-238
11. Gupta S., Leatham E. The relation between C. pneumoniae and atherosclerosis. Heart. 77:1997;7-8
12. Neumann F. Chlamydia pneumoniae-atherosclerosis link a sound concept in search for clinical relevance. Circulation. 106:2002;2414-2416
13. Bennedsen M., Berthelsen L., Lind I. Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G and A antibodies. Clin Diagn Lab Immunol. 9:2002;833-839
14. Caldwell H.A., Kromhout J., Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun. 31:1981;1161-1176
15. Gutierrez J., Mendoza J., Fernandez F., Linares-Palomino J., Soto M.J., Maroto M.C. ELISA test to detect Chlamydophila pneumoniae IgG. J Basic Microbiol. 42:2002;13-18
16. Gutierrez J., Linares-Palomino J., Lopez-Espada C., Rodriguez M., Ros E., Piedrola G., et al. Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease. Infection. 29:2001;196-200
17. Campbell L.A., Perez-Melgosa M., Hamilton D., Kuo C.C., Grayston J.T. Detection of C. pneumoniae by polymerase chain reaction. J Clin Microbiol. 30:1992;434-439
18. Hahn D.L., Golubjatnikov R. Smoking is a potential confounder of the C. pneumoniae coronary artery disease association. Arterioscle Thromb. 12:1992;945-947
19. Markus H., Sitzer M., Carrington D., Mendall M.A., Steinmetz H. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation. 100:1999;832-837
20. Toss H., Gnarpe J., Gnarpe H., Siegbahn A., Lindahl B., Wallentin L. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J. 19:1998;570-577
21. Dowell S.F., Peeling R.W., Boman J., Carlone G.M., Fields B.S., Guarner J., et al. Standardizing Chlamydia pneumoniae assays recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis. 33:2001;492-503
22. Mendall M.A., Carrington D., Strachan D., Patel P., Molineaux N., Levi J., et al. C. pneumoniae risk factors for seropositivity and association with coronary heart disease. J Infect. 30:1995;121-128
23. Karunakaran K., Blanchard J., Raudonikiene A., Shen C., Murdin A.D., Brunham R.C. Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1). J Clin Microbiol. 40:2002;4010-4014
24. Sessa R., DiPietro M., Schiavoni G., Santino I., Cipriani P., Romano S., et al. Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. Atherosclerosis. 159:2001;521-525
25. Mazzoli S., Tofani N., Fantini A., Semplici F., Bandini F., Salvi A., et al. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am Heart J. 135:1998;15-20
26. Porqueddu M., Spirito R., Parolari A., Zanobini M., Pompilio G., Polvani G., et al. Lack of association between serum immunoreactivity and Chlamydia pneumoniae detection in the human aortic wall. Circulation. 106:2002;2647-2648
27. Melnick S.L., Shahar E., Folsom A.R., Grayston J.T., Sorlie P.D., Wang S.P., et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) study investigators. Am J Med. 95:1993;499-504
28. Blanchard J., Armenian H., Peeling R., Friesen P.P., Shen C., Brunham R.C. The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm case-control study. Clin Infect Dis. 30:2000;946-947
29. Elkind M.S., Lin I.F., Grayston J.T., Sacco R.L. Chlamydia pneumoniae and the risk of first ischemic stroke the Northern Manhattan Stroke Study. Stroke. 31:2000;1521-1525
30. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Chlamydia pneumoniae IgG titres and coronary heart disease prospective study and meta-analysis. BMJ. 321:2000;208-213
31. Nieto F., Folsom A., Sorlie P., Grayston J.T., Wang S.P., Chambless L.E. Chlamydia pneumoniae infection and incident coronary heart disease the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 150:1999;149-156
32. Mahony J., Chongs S., Coombes B.K., Smieja M., Petrich A. Analytical sensibility, reproducibility of results and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells. J Clin Microbiol. 38:2000;2622-2627
33. Petersen E., Boman J., Persson K., Arnerlov C., Wadell G., Juto P., et al. Chlamydia pneumoniae in human abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 15:1998;138-142
34. Maass M., Krause E., Engel P., Kruger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology. 48:1997;699-706
35. Karlsson L., Gnarpe J., Naas J., Olsson G., Lindholm J., Steen B., et al. Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 19:2000;630-635
36. Ong G., Thomas B.J., Mansfield A.O., Davidson B.R., Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 49:1996;102-106
37. Maass M., Gieffers J., Krause E., Engel P.M., Bartels C., Solbach W. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. Med Microbiol Immunol. 187:1998;103-106
38. Ciufetti G., Mannarino E., Praticcia R. Leukocyte activity in chronic venous insufficiency. Int Angiol. 13:1994;312-316
39. Kuo C.C., Shor A., Campbell L.A., Fukushi H., Patton D.L., Grayston J.T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 167:1993;841-849
40. Grayston J.T., Kuo C.C., Coulson A.S., Campbell L.A., Lawrence R.D., Lee M.J., et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 92:1995;3397-3400
41. Chiu B., Viira E., Tucker W., Fong I.W. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in Atherosclerosis of the carotid artery. Circulation. 96:1997;2144-2148
42. Juvonen J., Juvonen T., Laurila A., Alakarppa H., Lounatmaa K., Surcel H.M., et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg. 25:1997;499-505
43. Maass M., Bartels C., Engel P.M., Mamat U., Sievers H.H. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 31:1998;827-832
44. Farsak B., Yildirir A., Akyon Y., Pinar A., Oc M., Boke E., et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol. 38:2000;4408-4411
45. Song Y.G., Kwon H.M., Kim J.M., Hong B.K., Kim D.S., Huh A.J., et al. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae. Yonsei Med J. 41:2000;319-327
46. Berger M., Schroder B., Daeschlein G., Schneider W., Busjahn A., Buchwalow I., et al. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J Lab Clin Med. 136:2000;194-200
47. Ouchi K., Fujii B., Kudo S., Shirai M., Yamashita K., Gondo T., et al. Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue. J Infect Dis. 181:(suppl):2000;441-443
48. LaBiche R., Koziol D., Quinn T.C., Gaydos C., Azhar S., Ketron G., et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke. 32:2001;855-860
49. Virok D., Kis Z., Karai L., Intzedy L., Burian K., Szabo A., et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke. 32:2001;1973-1976
50. Ong G.M., Coyle P.V., Barros D'Sa A.A., McCluggage W.G., Duprex W.P., O'Neill H.J., et al. Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis. 1:2001;12
51. Rassu M., Cazzavillan S., Scagnelli M., Peron A., Bevilacqua P.A., Facco M., et al. Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis. 158:2001;73-79
52. Taylor-Robinson D., Thomas B.J., Goldin R., Stanbridge R. Chlamydia pneumoniae in infrequently examined blood vessels. J Clin Pathol. 55:2002;218-220
53. Freidank H.M., Lux A., Dern P., Meyer-Konig U., Els T. Chlamydia pneumoniae DNA in peripheral venous blood samples from patients with carotid artery stenosis. Eur J Clin Microbiol Infect Dis. 21:2002;60-62
54. Shi Y., Tokunaga O. Enigmatic relationship between Chlamydia pneumoniae and atherosclerosis. Pathol Int. 53:2003;736-748
55. Neureiter D., Heuschmann P., Stintzing S., Kolominsky-Rabas P., Barbera L., Jung A., et al. Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis. 168:2003;153-162
56. Lin T.M., Chen W.J., Chen H.Y., Wang P.W., Eng H.L. Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation. J Clin Pathol. 56:2003;429-432
57. Sessa R., Di Pietro M., Schiavoni G., Santino I., Benedetti-Valentini F., Perna R., et al. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. J Vasc Surg. 37:2003;1027-1031